About Gilead Sciences, Inc.

Gilead Sciences, Inc. (NASDAQ: GILD) is a Healthcare company (Drug Manufacturers - General) with a market capitalization of $190.4B. Its Maz Rating is 3.61 out of 5 (B+, Buy), ranked against the other companies in its sector.

Factor scores: Valuation 1.51, Growth 3.36, Profitability 4.54, Financial Health 1.83, Momentum 4.19 (as of 2026-10-16).

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

US

CEO

Daniel O'Day

Employees

17,000

IPO date

1992-01-22